Berenberg Bank Reiterates Buy Rating for ANGLE (LON:AGL)

ANGLE (LON:AGL)‘s stock had its “buy” rating restated by analysts at Berenberg Bank in a research report issued to clients and investors on Wednesday, MarketBeat reports. They currently have a GBX 70 ($0.86) price objective on the stock. Berenberg Bank’s target price indicates a potential upside of 400.00% from the stock’s previous close.

ANGLE Price Performance

Shares of AGL opened at GBX 14 ($0.17) on Wednesday. The firm has a market capitalization of £36.48 million, a PE ratio of -154.08 and a beta of 0.20. The company has a debt-to-equity ratio of 14.26, a current ratio of 7.51 and a quick ratio of 6.18. ANGLE has a 1-year low of GBX 9.07 ($0.11) and a 1-year high of GBX 37.40 ($0.46). The company’s fifty day moving average price is GBX 14.41 and its 200-day moving average price is GBX 14.05.

ANGLE Company Profile

ANGLE plc, a medical diagnostic company, engages in developing cancer diagnostics products in Europe, North America, and the United Kingdom. The company develops and commercializes Parsortix cell separation system, which captures and harvests circulating tumor cells in metastatic breast cancer patient blood; and HyCEAD.